HomeWAVE • CVE
add
Waverley Pharma Inc
Previous close
$0.015
Year range
$0.010 - $0.035
Market cap
809.35K CAD
Avg Volume
1.83K
P/E ratio
-
Dividend yield
-
Primary exchange
CVE
Market news
Financials
Income Statement
Revenue
Net income
| (CAD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 275.66K | 1,129.68% |
Operating expense | 256.99K | 5.55% |
Net income | -237.99K | 12.80% |
Net profit margin | -86.33 | 92.91% |
Earnings per share | — | — |
EBITDA | -167.78K | 26.35% |
Effective tax rate | -0.69% | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 67.63K | -71.74% |
Total assets | 1.27M | -28.49% |
Total liabilities | 3.64M | -4.30% |
Total equity | -2.36M | — |
Shares outstanding | 54.00M | — |
Price to book | -0.38 | — |
Return on assets | -35.41% | — |
Return on capital | -50.09% | — |
Cash Flow
Net change in cash
| (CAD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -237.99K | 12.80% |
Cash from operations | -138.86K | -397.24% |
Cash from investing | 0.00 | 100.00% |
Cash from financing | 59.26K | -92.09% |
Net change in cash | -79.60K | -143.23% |
Free cash flow | -81.33K | -166.58% |
About
Founded
2014
Headquarters
Website
